demonstrated increased serum levels of aspartate aminotransferase (glutamic oxaloacetic transaminase, GOT), alanine aminotransferase (glutamic pyruvic transaminase, GPT), and of the liver-specific enzyme, ornithine carbamyl transferase (OCT), in patients with asthma. It was concluded that the increases in serum enzyme activity resulted from liver damage caused by the altered tensions of oxygen and carbon dioxide in the circulation. Subsequently, El-Shaboury, Thomas, and Williams (1964) the more anodic isoenzymes (LDH-1 and LDH-2) following myocardial infarction (Latner and Skillen, 1961) , and by the increase in the cathodic iso-enzyme (LDH-5) in diseases of the liver (Wilkinson, 1971 was increased significantly in the patients and this increase was distributed in the main between LDH-3 and LDH-5, with a somewhat smaller increase in LDH-4. The activities of the LDH-1 and LDH-2 fractions, however, were identical in the two groups. Typical densitometric scans of a normal subject and an asthma patient illustrate these differences (Figure) . The total LDH activity was not increased above the upper limit of normalcy (i.e., >mean+2SD) in every patient. This allowed division of the patients into two subgroups: I, six patients with significantly raised activities, and II, seven patients with activities within the normal range.
Comparison of group I with the normal group (Table I) total LDH activity during the two days following admission to hospital. In terms of the changes in the individual isoenzyme activities, the increases were mainly in the LDH-3 and LDH-5 fractions and to a lesser extent in LDH-4, in agreement with the overall picture observed on comparison of the patients with the normal subjects. These increments in activity took place in an improving clinical situation in both patients. Any assessment of the extent of day-to-day increases in isoenzyme activities is complicated by the different biological half-lives of the separate moieties, which vary from 8 hours for LDH-5 to 40 hours for LDH-1 (Boyd, 1967) . This is exemplified by the results from patient G. M. (Table II) , in whom LDH-5, LDH-4, and LDH-3 fell by 67%, 46%, and 28% respectively during a period of two days, whereas LDH-2 and LDH-1 remained unchanged. It was considered that such effects were minimal in terms of the isoenzyme distribution at the time of peak LDH activity.
RELATIONSHIPS WITH CLINICAL FACTORS Attempts to relate the changes in isoenzyme activities to clinical factors were abortive. The extent of the increase in total LDH activity was independent of either the severity of the asthmatic episode, as assessed clinically on admission, or of its duration. The paradox of waxing or waning of the total LDH activity in the presence of clinical improvement has already been noted.
Treatment with drugs either before or after hospital admission also did not influence the changes in activity. In particular, steroid therapy had been given to two patients for two days and to one patient for three weeks before admission. No progressive effect due to the length of treatment was detected, nor were the isoenzyme results in these patients different from those in the patients who did not receive steroids. The same conclusion was reached for the patients who received bronchodilator therapy, six in all, one of whom was the patient who had received steroids for three weeks. Antibiotic therapy was equally unrelated to the enzyme responses.
SOURCE OF ISOENZYME ACTIVITY The increases in isoenzyme activities described above require the organ or organs of origin to contain sizeable amounts of LDH-3 and LDH-5. The composition of lung tissue extract (Figure) , although showing all five isoenzymes, contained predominantly LDH-3 and LDH-4 and suggested that this tissue was the probable source of the increased activity of these moieties. This was supported by comparison of the mean increments in activity of the five isoenzyme species in the group I patients, which together contributed to the increase in mean total LDH activity of 166 U/I above normal, with the species distribution in lung tissue of an equivalent amount of total LDH activity (Table III) . Reasonable concordance between the values was apparent for LDH-1, LDH-2, and LDH-3, but LDH-4 was overestimated and LDH-5 underestimated. The discrepancy in the case of LDH-5 was probably more than that estimated, due to the short biological half-life of this entity, and indicated that its source was an alternative tissue. In view of the specific increase in serum OCT activity reported previously (Colldahl, 1960) , and the predominance of LDH-5 in liver-greater than 80% of the total LDH content (Cohen, Djordjevich, and Ormiste, 1964) -it appeared that this organ was the source of the increase in this fraction.
DISCUSSION
The technique used in this investigation for the separation and quantitation of the individual serum LDH isoenzymes has provided values in normal subjects comparable to those obtained previously by agarose electrophoresis (Elevitch, Aronson, Feichtmeir, and Enterline, 1966) , and, when applied to patients suffering asthma attacks, has shown increased activities due mainly to LDH-3 and LDH-5. Earlier work suggested that the raised levels of serum enzymes found in patients with asthma originated from the liver (Colldahl, 1960) . Support for this hypothesis was obtained from the nature of the enzymes released, in particular the increase of the activity of OCT, a liver specific enzyme (Reichard, 1960) , and from experimental studies on the effects of hypoxaemia and hypercapnia, both of which states are known to occur in asthma attacks (Lukas, 1951; Schiller and Lowell, 1954; Williams and Zohman, 1960) . Subjection of rats to either severe experimental asthma or to low oxygen and high carbon dioxide tensions resulted in increased serum GOT activity (Colldahl, 1943) . In addition, centrilobular necrosis has been detected at necropsy in 5% and steatosis in 23% of patients dying from asthma (Colldahl, 1971) . El-Shaboury et al. (1964) , however, found no correlation between serum GOT activity and liver function tests in patients suffering asthma attacks, and suggested that the increase in circulating enzyme activity may have arisen from lung tissue damaged by allergic reaction.
The present finding of an increased quotient of LDH-5 activity in asthma patients supports the premise that liver damage accompanies this condition. The associated increase in LDH-3 activity, however, cannot arise from this source, since liver is not abundant in this isoenzyme species.
LDH-3 activity is present in many tissues; those with the highest contents are pancreas, spleen, thyroid gland, adrenal gland, and lymph node, in all of which greater than 40% of the total LDH complement is present in this fraction (Wilkinson, 1971) . Lung represents the major tissue of second order abundance-the present investigation has shown 28% to be in the LDH-3 form, a value in close agreement with a previous estimate (Wroblewski and Gregory, 1961) .
Changes in isoenzyme distribution have been reported in cases of carcinoma of the bronchus (Wieme, van Hove, and van der Straeten, 1968) and in experimental pulmonary embolus (Bloor, Sobel, and Henry, 1970 Papadopoulos and Kintzios, 1967) .
These observations in conditions of pulmonary involvement suggest that lung tissue may be the source of the increase in LDH-3 activity in asthma. Support for this contention is provided by the close correlation between the absolute increase in activity of the isoenzyme in the circulation and the concentration of the same fraction in an aliquot of lung tissue of equivalent total LDH activity. It is possible that hypoxaemia may also play a part in such enzyme release from lung tissue by producing a transient but reversible alteration in membrane permeability. A similar change is seen in artificially induced stasis in muscle and results in increased levels of both LDH-3 and LDH-5 species. Restoration of the circulation promotes a return to normal levels, more rapidly in the former than in the latter fraction (Starkweather, Green, Spencer, and Schoch, 1966) . However, in view of the frequency of detection of increments in LDH-3 activity in a variety of clinical conditions (Wilkinson, 1971) , absolute definition of the source of this activity must await immunospecific identification of the tissue involved.
Past attempts to relate increases in serum GOT levels with prognosis in asthma patients have been unsuccessful (El-Shaboury et al., 1964) . The present finding of a lack of correlation between the clinical condition of the patient and the various isoenzyme levels, coupled with the further increases noted in certain clinically improved patients, indicates that the more specific assay is equally inapplicable for this purpose.
